Tag archive for ‘Teva Pharmaceutical’
Jewish Business News On Sunday, July 9th, 2017

Teva Ex-Exec Gave Trade Secrets Info to Her Lover, Rival Company’s CEO

    Apotex, the Canadian pharmaceutical giant, has used sensitive Teva trade secrets transferred to it by the company’s CEO, a former senior Teva executive, according to a lawsuit filed last week More...

Shiri Habib-Valdhorn On Tuesday, January 27th, 2015

Teva Rivals Urge US Court to Expedite Copaxone Suit

Copaxone’s patent remains in force at least until the Federal Circuit Appeals Court reconsiders the case. The rivals of Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) who are developing a generic More...

Globes On Monday, January 26th, 2015

Teva Gets First “Sell” Recommendation

Berenberg analysts see insurance companies pressuring MS patients to switch to generic versions of Copaxone. Last year, Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) posted its highest return on More...

Globes On Monday, January 12th, 2015

Perrigo Good Acquisition Candidate for Teva – Report

Bloomberg reports that increased competition with cheaper generics may push Teva to make a major acquisition soon. Perrigo Company (NYSE:PRGO; TASE:PRGO) may be a suitable acquisition for Teva Pharmaceutical Industries More...

Gil Tanenbaum On Friday, January 9th, 2015

Gamida Cell Has Success With Its Nicord Blood Cancer Medication

Israel’s Gamida Cell, a developer of cell therapy technologies and products for transplantation and adaptive immune therapy, announced that the first person has been successfully transplanted with cryopreserved More...

Teva Launches Generic Blood Pressure Treatment in US

– Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) has announced : the Food and Drug Administration (FDA) approval and the launch of the generic equivalent of Diovan (Valsartan) tablets in the More...

FDA Approves Teva Allergy Spray for Children

– The QNASL nasal spray, approved in 2012 for adults, treats nasal symptoms of allergic rhinitis, including hay fever, in children. Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) has More...

Globes On Wednesday, December 17th, 2014

US Court Delays Teva Launch of Generic Celebrex

– Teva has lost its 180 days exclusivity for the generic version of Pfizer’s arthritis and chronic pain treatment. –   The US Supreme Court of Appeal Court of Appeals has overturned the US More...

Koby Yeshayahou On Wednesday, December 17th, 2014

Brokerage Upgrades Teva Recommendation Following Copaxone Dosage Change

– “We are upgrading our recommendation for Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) from “Market perform” to “Market outperform” with a target price of $62 More...

Gali Weinreb On Wednesday, December 17th, 2014

BioLineRX Signs Novartis Strategic Cooperation Deal

– Novartis will invest $10 million in BioLineRX for a 12.8% stake. They will select three projects for joint development. –   Drug development company BiolineRX Ltd. (Nasdaq: BLRX); TASE:BLRX) More...

Email:

Delivered by FeedBurner